X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.fiercebiotech.com/biotech/yuhan-makes-325m-cancer-bet-challenge-boehringer-takeda
http://www.koreabiomed.com/news/articleView.html?idxno=13737
https://www.koreabiomed.com/news/articleView.html?idxno=12577
http://www.koreaherald.com/view.php?ud=20201123000807#:~:text=Yuhan%20gets%20%2465m%20from%20Janssen%20for%20lazertinib%20milestone%20achievement&text=Yuhan%20Corp.%20made%20a%20regulatory,milestone%20payment%20from%20Janssen%20Biotech.
http://www.koreaherald.com/view.php?ud=20200701000846
https://endpts.com/after-inking-a-string-of-pipeline-deals-boehringer-ingelheim-is-doing-a-makeover-of-the-top-executive-team/
https://www.biospace.com/article/bridge-biotherapeutics-licenses-fibrosis-compound-to-boehringer-ingelheim/
https://european-biotechnology.com/up-to-date/latest-news/news/boehringer-ingelheim-and-yuhan-corp-in-us870m-nash-deal.html
https://www.fiercepharma.com/pharma-asia/fiercepharmaasia-pfizer-plant-closures-gilead-yuhan-nash-pact-fujifilm-expansions
http://www.glenmarkpharma.com/sites/default/files/Glenmark-Pharma-enters-into-an-Exclusive-Licensing-Agreement-with-Yuhan-Corporation-for-commercializing-Investigational-Seasonal-Allergic-Rhinitis-Nasal-Spray-Ryaltris.pdf
Market Place
Share 
